Yan Z, Bing W, Ding C, Dong K, Ren J, Qu X
In addition, administration of harvested endothelial progenitor cells from GPx1 / mice failed to augment revascularization in wildtype mice, whereas the wildtype endothelial cells improved blood flow and capillary density in the GPx1 / mice, suggesting that elevated levels of ROS in the GPx1-deficient cells are detrimental to endothelial progenitor cell function [77]
(All committee members underwent the same ethics review and vetting process required of all FDA advisory committee members, Emily Hilliard, a spokesperson for the Department of Health and Human Services, told me in an email.) The decision is only a recommendation, and the FDA would still need to sign off on an actual rule change
May Prevent Major Birth Defects